Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.620
+0.010 (0.62%)
Aug 13, 2025, 4:00 PM - Market closed
APUS Market Cap
APUS has a market cap or net worth of $18.75 million as of August 14, 2025.
Market Cap
18.75M
Enterprise Value
19.47M
1-Year Change
n/a
Ranking
Category
Stock Price
1.62
Market Cap Chart
Since the IPO on May 9, 2025, APUS's market cap has decreased from $25.45M to $18.75M, a decrease of -26.32%. That is a compound annual growth rate of -68.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 18.75M | -26.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 569.81B |
| Johnson & Johnson | 416.26B |
| AbbVie | 349.64B |
| UnitedHealth Group | 235.98B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.61B |
| Novo Nordisk | 222.88B |